Novavax’s COVID-19 vaccine approved for Canadians 18 and older
Novavax’s COVID-19 vaccine has been approved for use in Canadian adults, some 18 months after the federal government had announced a deal to produce the doses in Montreal.A worker moves boxes carrying Novavax Inc.’s COVID-19 vaccine, Nuvaxovid, in Andong, South Korea on Feb. 9. South Korea is among several countries who have been administering the…